81 search results for Lung

NCCN SOSF 2024 Thirteenth Annual Summary

, NCCN Panelists included: • Arun Krishna, PhD, Vice-President, US Franchise Head & Lung Cancer, featured on the panel. Dr. Krishna discussed the importance of lung cancer screening because the U.S., challenges and focuses on education and processes to improve screening uptake. Mobile lung and mammography

https://www.nccn.org/docs/default-source/oncology-policy-program/nccn-sosf-2024-thirteenth-annual-summary.pdf?sfvrsn=5346b0f5_1

Treatment by Cancer Type

Version: 1.2025 Non-Small Cell Lung Cancer, Small Cell Lung Cancer Version: 4.2025

https://www.nccn.org/guidelines/category_1

30 Years of NCCN

care and outcomes. The first disease types available were: Acute Leukemia and Breast, Colon, Lung

https://www.nccn.org/home/about/nccn-history/30-years-of-nccn

Young Investigator Awards

to Improve Lung Cancer Screening Among Black Veterans Ravi Parikh, MD, MPP, The Abramson

https://www.nccn.org/education-research/nccn-oncology-research-program/young-investigator-awards

Young Investigator Awards

Neelima Navuluri, MD, MPH, Duke Cancer Institute Intervention Mapping to Improve Lung Cancer

https://www.nccn.org/patientresources/patient-resources/nccn-foundation/young-investigator-awards

Calendar of Events

to the Management of Resectable Non-Small Cell Lung Cancer Earn CE credit. EVENT

https://www.nccn.org/education-research/educational-events-and-programs/calendar-of-events

lms_redirect

of Resectable Non-Small Cell Lung Cancer 1.00 AAPA Category 1 CME credit 1.00 ACPE contact hours 1.00

https://www.nccn.org/lms_redirect

Ways to Give

interested in giving toward specific areas of cancer (i.e. breast cancer, lung cancer, etc.) should

https://www.nccn.org/patientresources/patient-resources/nccn-foundation/ways-to-give

Member Institution Toolkit

the Date! NCCN 2025 Lung Cancer Congress Earn CE credit. | In-person and virtual attendance

https://www.nccn.org/members/member-institution-portal/member-institution-toolkit

Guidelines With Evidence Blocks

Neuroendocrine and Adrenal Tumors Version 1.2025 Non-Small Cell Lung Cancer, Version 2.2025 Small Bowel Adenocarcinoma Version 3.2025 Small Cell Lung Cancer

https://www.nccn.org/guidelines/guidelines-with-evidence-blocks

Chemotherapy Order Templates Reviewer Acknowledgement

, BCOP Mayo Clinic Comprehensive Cancer Center Non-Small Cell Lung, Institute at the University of Utah Small Cell Lung Cancer Sally

https://www.nccn.org/compendia-templates/nccn-templates-main/nccn-chemotherapy-order-reviewer-engagement

2021_Elevating_Cancer_Equity_Webinar_Slides

                        Prostate Cancer Lung Cancer 13 © National Comprehensive Cancer Network, Inc. 2021, All Rights, Prevalence Va r i e s G e o g raphically 2017 Medicare Population 25 Lung Cancer Prostate Cancer

https://www.nccn.org/docs/default-source/oncology-policy-program/2021_elevating_cancer_equity_webinar_slides.pdf?sfvrsn=e11f66e4_4

Permission to Cite or Use NCCN Content FAQ

, e.g.: …MCL, mantle cell lymphoma; NCCN, National Comprehensive Cancer Network; SCLC, small cell lung

https://www.nccn.org/guidelines/submissions-licensing-and-permissions/permission-to-cite-or-use-nccn-content-faq

Employer Toolkit

Guidelines; NCCN Guidelines for Patients: Lung Cancer Screening; NCCN Guidelines for Detection

https://www.nccn.org/business-policy/business/employer-resources/employer-toolkit

RRR PDF 2021

Boxed WARNINGS for Interstitial Lung Disease and Embryo-Fetal Toxicity, and click here for Medication

https://www.nccn.org/docs/default-source/business-policy/rrr-pdf-2021.pdf?sfvrsn=99028107_8
20 of 81 results